Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leber's Hereditary Optic Neuropathy, Normal Tension Glaucoma, and Flammer Syndrome: Long Term Follow-up of a Patient.

Klinische Monatsblatter fur Augenheilkunde·2017
Same author

[Phenomenology and Clinical Relevance of the Flammer Syndrome].

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome.

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

The effect of hypoxia on intra-ocular, mean arterial, retinal venous and ocular perfusion pressures.

Clinical hemorheology and microcirculation·2015
Same author

Predictability of morphological changes of the anterior chamber angle after laser iridotomy by ultrasound biomicroscopy.

Klinische Monatsblatter fur Augenheilkunde·2015
Same author

Comparing Short-Duration Electro-Oculograms with and without Mydriasis in Healthy Subjects.

Klinische Monatsblatter fur Augenheilkunde·2015

Related Experiment Video

Updated: Jun 18, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Headache in normal-tension glaucoma patients.

S Orgül1, J Flammer

  • 1University Eye Clinic Basel, Basel, Switzerland.

Journal of Glaucoma
|November 19, 2009
PubMed
Summary

Headache may indicate a specific subgroup of normal-tension glaucoma (NTG) patients. NTG patients with headaches had significantly lower intraocular pressure (IOP) than those without headaches.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Headache, including migraine, is a potential risk factor for normal-tension glaucoma (NTG).
  • The relationship between headache and NTG, independent of intraocular pressure (IOP), requires clarification.

Purpose of the Study:

  • To compare intraocular pressure (IOP) between normal-tension glaucoma (NTG) patients with and without headaches.
  • To investigate if headache is an independent factor associated with lower IOP in NTG.

Main Methods:

  • Compared mean IOP in NTG patients with (n=14) and without (n=9) headache.
  • Performed an analogous comparison in non-glaucomatous control subjects (n=23) with (n=13) and without (n=10) headache.
  • Ensured glaucoma and control groups were matched for sex, age, and mean IOP.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Related Experiment Videos

Last Updated: Jun 18, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Main Results:

  • NTG patients with headache exhibited significantly lower mean IOP (p = 0.0004) compared to NTG patients without headache.
  • This IOP difference was observed despite comparable glaucomatous visual-field damage in both NTG subgroups.
  • No significant IOP difference was found between headache and non-headache groups in non-glaucomatous controls.

Conclusions:

  • Headache appears to identify a distinct subgroup within the normal-tension glaucoma population.
  • The findings suggest headache may be associated with lower intraocular pressure in NTG, independent of visual field status.